MICHELLE OETJENS: Open Payments
NPI 1821622937 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 4 payments from 4 companies in 2025. Trend: 2023 $425 · 2024 $255 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 1 | $92 |
| GlaxoSmithKline, LLC. | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 1 | $85 |
| Galderma Laboratories, L.P. | 1 | $30 |
Products named: Xolair, DUPIXENT, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
